IMVT

IMVT Operating Cash Flow Growth

0.67%TTM

Period ending:

IMVT TTM Cash from Operations YoY %%
IMVT TTM Cash from Operations YoY %1009.40%-9414.18%
2020-03-312026-06-30

Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.

IMVT operating cash flow growth history

Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 26 observations from Mar 31, 2020 to Jun 30, 2026.

Immunovant Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
0.667%
-8.3634%
-30.145%
-58.6472%
-71.6008%
-75.4559%
-54.4953%
-29.5895%
-43.1897%
-13.8337%
-27.1928%
-38.9524%
-12.6243%
-77.3532%
-72.8725%
-74.255%
-66.0922%
-27.3441%
-14.033%
-41.7577%
-144.2353%
-253.287%
-8,405.4497%
-629.6872%
-222.7002%
-44.2834%

Compare operating cash flow growth

All IMVT financial metrics · IMVT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.